PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q4 2020. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $15,454,101 | +134.9% | 641,249 | +3.0% | 0.00% | +200.0% |
Q4 2022 | $6,578,282 | +158.8% | 622,354 | +10.1% | 0.00% | 0.0% |
Q3 2022 | $2,542,000 | +22.9% | 565,062 | +9.3% | 0.00% | – |
Q2 2022 | $2,069,000 | -45.8% | 517,132 | -0.8% | 0.00% | -100.0% |
Q1 2022 | $3,817,000 | +25.8% | 521,547 | -3.4% | 0.00% | – |
Q4 2021 | $3,033,000 | -16.3% | 539,823 | -4.7% | 0.00% | -100.0% |
Q3 2021 | $3,624,000 | -24.9% | 566,205 | -1.1% | 0.00% | 0.0% |
Q2 2021 | $4,826,000 | -23.0% | 572,603 | -4.2% | 0.00% | 0.0% |
Q1 2021 | $6,271,000 | -36.0% | 597,581 | +3.4% | 0.00% | -50.0% |
Q4 2020 | $9,791,000 | +29.3% | 578,026 | -2.1% | 0.00% | 0.0% |
Q3 2020 | $7,575,000 | +155.5% | 590,417 | +181.1% | 0.00% | +100.0% |
Q2 2020 | $2,965,000 | +352.7% | 210,051 | +194.9% | 0.00% | – |
Q1 2020 | $655,000 | -34.5% | 71,228 | +6.1% | 0.00% | – |
Q4 2019 | $1,000,000 | +191.5% | 67,129 | +33.6% | 0.00% | – |
Q3 2019 | $343,000 | -6.8% | 50,259 | +65.1% | 0.00% | – |
Q2 2019 | $368,000 | – | 30,448 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |